Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 252-862-4 | CAS number: 36078-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 28 Jun - 21 Jul 1994
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP-guideline study with acceptable restrictions. Short treatment period (Day 6-15 of gestation), body weight was recorded on Day 0, 6, 16 and 20 only, food consumption was not recorded, the analytical purity of the test substance was not specified.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- yes
- Remarks:
- exposure from Day 6 to Day 15 of gestation, body weight was recorded on Day 0, 6, 16 and 20, food consumption was not recorded
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 111937-03-2
- EC Number:
- 601-141-6
- Cas Number:
- 111937-03-2
- IUPAC Name:
- 111937-03-2
- Details on test material:
- - Name of test material (as cited in study report): isononanoic acid, mixed hexadecyl-octadecyl esters
- Physical state: colourless liquid
- Analytical purity: no data
- Lot/batch No.: 27533249
- Expiration date of the lot/batch: Sep 1994
- Storage condition of test material: at room temperature in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley, CD
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Wiga GmbH, Sulzfeld, Germany
- Age at study initiation: 8 weeks
- Weight at study initiation: 202.6 ± 20.4 g - 219 ± 25.6 g (range of group mean values)
- Housing: the animals were housed individually in Makrolon Type M3 cages (Ebeco, Castrop-Rauxel, Germany), on standard softwood bedding (ARWI-Center, Essen, Germany)
- Diet: pelleted Altromin Maintenance Diet 1324 (Fa. Altromin GmbH, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 48-82
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12 (lux units 50 - 550)
IN-LIFE DATES: From: 28 Jun 1994 To: 21 Jul 1994
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: 0.5% sodium carboxymethylcellulose + 0.25% Cremophor in aqua dest.
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item was prepared daily before administration, adjusted to the body weight measured on Day 6 of gestation.
VEHICLE
- Concentration in vehicle: 1, 3, 10% (10, 30, 100 mg/mL)
- Amount of vehicle (if gavage): 10 mL/kg bw - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The mixture of the test item was analysed once to verify the actual concentration. The measured concentration was within the expected range. The nominal concentrations 1 % (100 mg/kg bw/day), 3 % (300 mg/kg bw/day) and 10 % (1000 mg/kg bw/day) were measured to be 1.1%, 3.0% and 10.5%, respectively.
- Details on mating procedure:
- - Any other deviations from standard protocol: Primiparous time-mated females were used. The females were mated at the supplier with an accurate day of mating and received at the testing facility on gestation day 0.
- Duration of treatment / exposure:
- Day 6-15 of gestation
- Frequency of treatment:
- daily, 7 days/week
- Duration of test:
- 10 days; Day 6-15 of gestation
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300 and 1000 mg/kg bw/day
Basis:
other: nominal dose
- No. of animals per sex per dose:
- 23 P females (100 and 300 mg/kg bw/day)
24 P females (control, 1000 mg/kg bw/day) - Control animals:
- yes, concurrent vehicle
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily
DETAILED CLINICAL OBSERVATIONS: No
BODY WEIGHT: Yes
- Time schedule for examinations: on Day 0 (prior to administration), 6, 16 and 20 of gestation
FOOD CONSUMPTION: No
WATER CONSUMPTION: No
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 20
- Organs examined: gross macroscopic examination of all reproductive and gender-specific organs, with emphasis on the uterus, uterine contents, position of the fetuses in the uterus and number of corpora lutea - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
- Other: weight of fetuses - Fetal examinations:
- - External examinations: Yes, all fetuses
- Soft tissue examinations: Yes, half per litter (146 fetuses of group 1, 133 fetuses in group 2, 169 fetuses in group 3 and 162 fetuses in group 4)
- Skeletal examinations: Yes, half per litter (159 fetuses of group 1, 144 fetuses in group 2, 178 fetuses in group 3 and 172 fetuses in group 4)
- Head examinations: No
Group 1: control
Group 2: 100 mg/kg bw/day
Group 3: 300 mg/kg bw/day
Group 4: 1000 mg/kg bw/day - Statistics:
- If the variables could be assumed to follow a normal distribution, the Dunnett-Test, based on pooled variance, was applied for comparion between groups. The Steel-Test was applied when the data could not be assumed to follow a normal distribution. Fisher's Exact test for 2x2 tables was applied if the variables could be dichotomized without loss of information (Bonferroni-Holm-corrected).
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:no effects
Details on maternal toxic effects:
There was no mortality during the study period. No signs of systemic toxicity were observed. The mean body weight of the mid-dose group was statistically significantly increased on Day 16 and 20 of the study period (see Table 1). This considered to be an incidental observation, as the body weight gain over the study period was comparable between the control and treatment groups (58.9, 67.8, 57.4 and 59.6 g for the control, 100, 300 and 1000 mg/kg bw/day group, respectively). One female in each of the control group and the low-dose group was not pregnant, while all the pregnant females had viable fetuses (see Table 2).
No substance-related effects on the reproductive parameters (number of corpora lutea, implantation sites, pre-implantation loss, post-implantation loss, embryonic deaths, embryonic resorptions, fetal resorptions, live fetuses, dead fetuses) were observed (see Table 3). The necropsy and macroscopic examination did not show any treatment-related effects. One female in the high-dose group had blood in the uterine horn, but this is not considered to be treatment-related as no other effects were observed.
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: developmental toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
The external examination of the foetuses did not reveal any treatment-related macroscopical effects. The skeletal examination showed a statistically significant increase in the number of foetuses with 6 ossified sternebrae in the high-dose group (see Table 5). As there were no increases in ossification anywhere else and no overall increase in abnormal findings for this group, the result is considered to be incidental. The results for the remaining offspring parameters (body weight, placental weight, sex ratio) were comparable between the control and treatment groups.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Table 1: Body weights
Dose group |
Control |
100 mg/kg bw/day |
300 mg/kg bw/day |
1000 mg/kg bw/day |
Gestation day 0 |
212.3 |
202.6 |
219.7 |
209.0 |
Gestation day 6 |
263.1 |
255.5 |
273.5 |
259.4 |
Gestation day 16 |
340.7 |
338.6 |
361.7* |
341.5 |
Gestation day 20 |
403.3 |
400.7 |
428.0* |
407.9 |
*Dunnett-Test based on pooled variance, p < 0.05
Table 2: Summary of mating performance of the females
Dose group
|
Control |
100 mg/kg bw/day |
300 mg/kg bw/day |
1000 mg/kg bw/day |
No. of mated females |
24 |
23 |
23 |
24 |
No. of pregnant females* |
23 |
22 |
23 |
24 |
No. of premature litters** |
0 |
0 |
0 |
0 |
No. of mortalities |
0 |
0 |
0 |
0 |
*Included in the statistical analysis
**Premature litter is an event in the cage immediately before the caesarean section
Table 3: Reproduction parameters for dams with live foetuses
Dose group
|
Control |
100 mg/kg bw/day |
300 mg/kg bw/day |
1000 mg/kg bw/day |
Number of dams |
23 |
22 |
23 |
24 |
Corpora lutea (total) |
376 |
343 |
403 |
390 |
Corpora lutea (mean±SD) |
16.3±1.5 |
15.6±1.2 |
17.5±1.6 |
16.2±2.3 |
Implantation sites (total) |
316 |
301 |
367 |
346 |
Implantation sitesaas: -% of corp. lutea - mean±SD |
84.0 13.7±3.7 |
87.8 13.7±2.5 |
91.1 16.0±1.9 |
88.7 14.4±3.1 |
Pre-implantation loss (total)b |
60 |
42 |
36* |
44 |
Pre-Implantation lossas % of corpora lutea |
16.0 |
12.2 |
8.9 |
11.3 |
Post-implantation lossb |
11 |
24 |
20 |
12 |
Post-implantation loss as % of implantation sites |
3.5 |
8.0 |
5.4 |
3.5 |
Embryonic deaths totalb |
11 |
24 |
20 |
12 |
Embryonic resorptions (total)a |
9 |
18 |
20 |
10 |
Embryonic resorptions as % of implantation sites (mean±SD) |
2.8±0.4 |
6.0±0.8 |
5.4±0.9 |
2.9±0.4 |
Foetal resorptions (total)a |
2 |
6 |
0 |
2 |
Foetal resorptionsas % of implantation sites(mean±SD) |
0.6±0.1 |
2.0±0.3 |
0 |
0.6±0.1 |
Fetuses per dam (mean±SD) |
13.3±3.6 |
12.6±3.1 |
15.1±2.4 |
13.9±2.7 |
Live foetusesa |
305 |
277 |
347 |
334 |
Dead foetusesa |
0 |
0 |
0 |
0 |
Malformed foetuses |
0 |
0 |
0 |
0 |
Uterus weightc(mean±SD) |
81.3±24.1 |
77.4±18.0 |
97.0±15.7* |
88.8±18.3 |
aSteel Test
bFishers Exact Test (Bonferroni-Holm-Corrected)
cDunnett-Test based on pooled variance
*p < 0.05
Table 4: Developmental parameters for offspring
Dose group
|
Control |
100 mg/kg bw/day |
300 mg/kg bw/day |
1000 mg/kg bw/day |
Number of live foetuses (m/f) |
305 (154/151) |
277 (141/136) |
347 (162/185) |
334 (165/169) |
Sex ratio (m/f) |
0.51/0.49 |
0.51/0.49 |
0.47/0.53 |
0.49/0.51 |
Weights of live foetuses (mean±SD) |
4.1±0.8 |
4.1±0.6 |
4.4±0.8 |
4.2±0.6 |
No. of runts |
1 |
2 |
1 |
2 |
Table 5: results of skeletal examination of offspring
Dose group
|
Control |
100 mg/kg bw/day |
300 mg/kg bw/day |
1000 mg/kg bw/day |
No abnormal findings, number (% of total) |
10 (6.3%) |
12 (8.3%) |
32 (18.0%)** |
10 (5.8%) |
6 ossified sternebrae, number (% of total) |
124 (78.0%) |
120 (83.3%) |
151 (84.8%) |
153 (89%)** |
** Fishers Exact Test (two-sided), p < 0.01
Applicant's summary and conclusion
- Conclusions:
- The test substance had no effect on intrauterine development
CLP: not classified
DSD: not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.